Responsiveness of human immunodeficiency virus type 1-infected Kenyan women with or without prior pneumococcal disease to pneumococcal vaccine

Journal of Infectious Diseases

Volumn 175, Issue 4, 1997, Pages 975-978

  Janoff, Edward N ^a   Fasching, Claudine ^b   Ojoo, Josephine C ^b   O'Brien, James ^b   Gilks, Charles F ^b  

^a VA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; KENYA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0030894752     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514004     Document Type: Article

References (15)

1. Gilks CF, Brindle RJ, Otieno LS, et al. Life-threatening bacteraemia in HIV-I seropositive adults admitted to hospital in Nairobi, Kenya. Lancet 1990;336:545-9.
2. Gilks CF, Ojoo SA, Ojoo JC, et al. Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya. Lancet 1996;347:718-23.
3. Redd SC, Rutherford GW, Sande MA, et al. The role of human immunodeficiency virus in pneumococcal bacteremia in San Francisco residents. J Infect Dis 1990;162:1012-7.
4. Bruyn GAW, Zegers BJM, van Furth R. Mechanisms of host defense against infection with Streptococcus pneumoniae. Clin Infect Dis 1992;14:251-62.
5. Simonsen JN, Plummer FA, Ngugi EN, et al. HIV infection among lower socioeconomic strata prostitutes in Nairobi. AIDS 1990;4:139-44.
6. Carson PJ, Schut RL, Simpson ML, O'Brien J, Janoff EN. Antibody class and subclass responses to pneumococcal polysaccharides following immunization of human immunodeficiency virus-infected patients. J Infect Dis 1995;172:340-5.
7. Gray BM. Opsonophagocidal activity in sera from infants and children immunized with Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate). Pediatrics 1990;85:694-7.
8. Miculek S, Anderson EL, Gray BM. Opsonophagocidal antibodies to pneumococcus group 6 in infants and children given a new polysaccharide conjugate vaccine. Clin Res 1991;39:842A.
9. Janoff EN, O'Brien J, Thompson P, et al. Streptococcus pneumoniae colonization, bacteremia, and immune response among persons with human immunodeficiency virus infection. J Infect Dis 1993;167:49-56.
10. Romero-Steiner S, Pais L, Holder P, Carlone GM, Keyserling HL. Opsono-phagocytosis of Streptococcus pneumoniae as an indicator of functional antibody activity in adults vaccinated with a 23-valent polysaccharide vaccine (abstract E42). In: Proceedings of the 95th annual meeting of the American Society for Microbiology (Washington, DC). Washington, DC: ASM, 1995.
11. Skubitz KM, Zhen Y, August JT. Dexamethasone synergistically induces chemotactic peptide receptor expression in HL-60 cells. Blood 1984;59:596-3.
12. Janoff EN, Breiman RF, Daley CL, Hopewell PC. Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives. Ann Intern Med 1992;117:314-24.
13. American College of Physicians Task Force on Adult Immunization, Infectious Diseases Society of America. Guide for adult immunization. 3rd ed. Philadelphia: American College of Physicians, 1994:50-9.
14. Salisbury DM, Begg NT. Pneumococcal vaccination in 1996. Immunisation against infectious diseases. London: Her Majesty's Stationery Office, 1996:169-72.
15. Amdahl BM, Rubins JB, Daley CL, Gilks CF, Hopewell PC, Janoff EN. Impaired natural immunity to pneumolysin during human immunodeficiency virus infection in the United States and Africa. Am J Respir Crit Care Med 1995;152:2000-4.